Betahistin-Mepha Teva 16 mg
Betahistin-Mepha Teva 16 mg is a medicine authorised by Swissmedic under authorisation number 68912. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 August 2023 and the authorisation is limited until 03 August 2028. ATC code N07CA01 places the medicine in the group Other nervous system drugs.
| Authorisation number | 68912 |
|---|---|
| Name | Betahistin-Mepha Teva 16 mg |
| Full name | Betahistin-Mepha Teva 16 mg, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N07CA01 |
| First authorisation | 04 August 2023 |
| Authorisation validity | 03 August 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Betahistin-Mepha Teva 16 mg, Tabletten | B | 04 August 2023 |
| 2 | Betahistin-Mepha Teva 24 mg, Tabletten | B | 04 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 50 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 2 | 100 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 3 | 50 | Tablette(n) | N07CA01 | 02.04.4. | B |
| 4 | 100 | Tablette(n) | N07CA01 | 02.04.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Betahistin-Mepha Teva 16 mg authorised in Switzerland?
Yes. Betahistin-Mepha Teva 16 mg is authorised by Swissmedic under authorisation number 68912, data as of 01 September 2026. The authorisation is limited until 03 August 2028.
Which dispensing category does Betahistin-Mepha Teva 16 mg have?
Betahistin-Mepha Teva 16 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Betahistin-Mepha Teva 16 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.